Kissei Pharmaceutical Co., Ltd.

OTCPK:KSPH.F Lagerbericht

Marktkapitalisierung: US$1.1b

Kissei Pharmaceutical Zukünftiges Wachstum

Future Kriterienprüfungen 0/6

Kissei Pharmaceutical's earnings are forecast to decline at 6.8% per annum while its annual revenue is expected to grow at 4.1% per year. EPS is expected to decline by 6.6% per annum. Return on equity is forecast to be 3.7% in 3 years.

Wichtige Informationen

-6.8%

Wachstumsrate der Gewinne

-6.6%

EPS-Wachstumsrate

Pharmaceuticals Gewinnwachstum23.7%
Wachstumsrate der Einnahmen4.1%
Zukünftige Eigenkapitalrendite3.7%
Analystenabdeckung

Low

Zuletzt aktualisiert03 Sep 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Gewinn- und Umsatzwachstumsprognosen

OTCPK:KSPH.F - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (JPY Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
3/31/202789,3648,0578,414N/A3
3/31/202685,4499,06711,712N/A3
3/31/202583,85511,9675,031N/A4
6/30/202477,43012,001N/AN/AN/A
3/31/202475,57911,160-3,510-1,677N/A
12/31/202373,71712,198N/AN/AN/A
9/30/202371,60712,880-8,350-5,854N/A
6/30/202370,52112,158N/AN/AN/A
3/31/202367,49310,528-9,226-6,679N/A
12/31/202266,93112,769N/AN/AN/A
9/30/202265,85710,581-4,543-2,556N/A
6/30/202265,03110,912N/AN/AN/A
3/31/202265,38112,921-3861,533N/A
12/31/202166,9345,664N/AN/AN/A
9/30/202169,1486,555-2,042-349N/A
6/30/202169,6187,204N/AN/AN/A
3/31/202169,0445,285-4,027-2,542N/A
12/31/202066,8775,715N/AN/AN/A
9/30/202063,9705,063-573683N/A
6/30/202063,1962,530N/AN/AN/A
3/31/202063,2342,81712,63213,934N/A
12/31/201965,5944,753N/AN/AN/A
9/30/201968,1804,2949,18910,431N/A
6/30/201970,5454,752N/AN/AN/A
3/31/201972,2975,4815,0136,346N/A
12/31/201872,4745,263N/AN/AN/A
9/30/201873,0878,10212,15913,854N/A
6/30/201873,0149,685N/AN/AN/A
3/31/201874,0099,045N/A8,845N/A
12/31/201773,8878,735N/AN/AN/A
9/30/201772,4598,116N/A5,756N/A
6/30/201771,3966,993N/AN/AN/A
3/31/201771,7067,726N/A6,441N/A
12/31/201672,1546,401N/AN/AN/A
9/30/201673,5338,108N/A9,023N/A
6/30/201673,7748,734N/AN/AN/A
3/31/201671,2948,165N/A5,763N/A
12/31/201571,2398,521N/AN/AN/A
9/30/201569,0956,608N/A2,948N/A
6/30/201570,9457,161N/AN/AN/A
3/31/201570,1107,165N/A6,667N/A
12/31/201469,6667,829N/AN/AN/A
9/30/201473,0909,817N/A9,538N/A
6/30/201469,9348,935N/AN/AN/A
3/31/201470,3999,093N/A11,945N/A
12/31/201369,3359,365N/AN/AN/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: KSPH.F's earnings are forecast to decline over the next 3 years (-6.8% per year).

Ertrag vs. Markt: KSPH.F's earnings are forecast to decline over the next 3 years (-6.8% per year).

Hohe Wachstumserträge: KSPH.F's earnings are forecast to decline over the next 3 years.

Einnahmen vs. Markt: KSPH.F's revenue (4.1% per year) is forecast to grow slower than the US market (8.9% per year).

Hohe Wachstumseinnahmen: KSPH.F's revenue (4.1% per year) is forecast to grow slower than 20% per year.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: KSPH.F's Return on Equity is forecast to be low in 3 years time (3.7%).

Wachstumsunternehmen entdecken

7D

1Y

7D

1Y

7D

1Y